Literature DB >> 21292502

Management of gut inflammation through the manipulation of intestinal dendritic cells and macrophages?

Liat Bar-On1, Ehud Zigmond, Steffen Jung.   

Abstract

Inflammatory bowel diseases (IBDs) including Crohn's disease and ulcerative colitis represent a major challenge to clinicians and immunologists trying to understand why in certain individuals the peaceful coexistence of the commensal microflora and its host breaks down and results in chronic inflammation. Here we summarize the recent progress in our understanding of the organization of the intestinal mononuclear phagocytes with dendritic cells and macrophages of distinct phenotype, origin and function. Finally, we discuss potential strategies to translate the recent findings into the management of chronic inflammation in animal models of IBD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21292502     DOI: 10.1016/j.smim.2011.01.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  16 in total

Review 1.  Dendritic cells: novel players in fibrosis and scleroderma.

Authors:  Theresa T Lu
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 2.  Microbial activation of gut dendritic cells and the control of mucosal immunity.

Authors:  Jennifer L Owen; Mansour Mohamadzadeh
Journal:  J Interferon Cytokine Res       Date:  2013-08-20       Impact factor: 2.607

3.  Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model.

Authors:  Wei Wang; Xiayu Li; Danwei Zheng; Decai Zhang; Shuo Huang; Xuemei Zhang; Feiyan Ai; Xiaoyan Wang; Jian Ma; Wei Xiong; Yanhong Zhou; Guiyuan Li; Shourong Shen
Journal:  Inflamm Res       Date:  2013-04-27       Impact factor: 4.575

Review 4.  Helminthic therapy: improving mucosal barrier function.

Authors:  Martin J Wolff; Mara J Broadhurst; P'ng Loke
Journal:  Trends Parasitol       Date:  2012-03-28

5.  Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells.

Authors:  Anna Bunin; Vanja Sisirak; Hiyaa S Ghosh; Lucja T Grajkowska; Z Esther Hou; Michelle Miron; Cliff Yang; Michele Ceribelli; Noriko Uetani; Laurence Chaperot; Joel Plumas; Wiljan Hendriks; Michel L Tremblay; Hans Häcker; Louis M Staudt; Peter H Green; Govind Bhagat; Boris Reizis
Journal:  Immunity       Date:  2015-07-28       Impact factor: 31.745

6.  Restored Macrophage Function Ameliorates Disease Pathophysiology in a Mouse Model for IL10 Receptor-deficient Very Early Onset Inflammatory Bowel Disease.

Authors:  Mania Ackermann; Adele Mucci; Amanda McCabe; Sandy Frei; Kayla Wright; Scott B Snapper; Nico Lachmann; David A Williams; Christian Brendel
Journal:  J Crohns Colitis       Date:  2021-09-25       Impact factor: 9.071

Review 7.  Nematode modulation of inflammatory bowel disease.

Authors:  Rose A K Whelan; Susanne Hartmann; Sebastian Rausch
Journal:  Protoplasma       Date:  2011-11-17       Impact factor: 3.356

Review 8.  Mucosal macrophages in intestinal homeostasis and inflammation.

Authors:  Allan McI Mowat; Calum C Bain
Journal:  J Innate Immun       Date:  2011-09-19       Impact factor: 7.349

9.  MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice.

Authors:  Namiko Hoshi; Dominik Schenten; Simone A Nish; Zenta Walther; Nicola Gagliani; Richard A Flavell; Boris Reizis; Zeli Shen; James G Fox; Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF.

Authors:  Nobuyasu Baba; Vu Quang Van; Keiko Wakahara; Manuel Rubio; Geneviève Fortin; Benoît Panzini; Geneviève Soucy; Ramses Wassef; Carole Richard; Raja Tamaz; Raymond Lahaie; Edmond-Jean Bernard; Yves Caussignac; Raymond Leduc; Rasmy Lougnarath; Carole Bergeron; Marc-André Racicot; Fanny Bergeron; Marie-Andrée Panzini; Pieter Demetter; Denis Franchimont; Knut Schäkel; Gisbert Weckbecker; Frank Kolbinger; Christoph Heusser; Thomas Huber; Karl Welzenbach; Marika Sarfati
Journal:  J Exp Med       Date:  2013-05-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.